{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T04:04:56Z","timestamp":1749182696714,"version":"3.41.0"},"reference-count":21,"publisher":"Jaypee Brothers Medical Publishing","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.59556\/japi.73.0843","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T07:34:21Z","timestamp":1749108861000},"page":"40-49","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Spectrum and Therapeutic Outcome of Myasthenia Gravis in a Tertiary Care Hospital: A Retrospective Study"],"prefix":"10.59556","volume":"73","author":[{"given":"Sujaya","family":"Raghavendra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jawahar","family":"Marimuthu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisy Precilla","family":"Senthilathiban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balasubramanian","family":"Samivel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","reference":[{"issue":"(3):","key":"key20250605073415_B1","doi-asserted-by":"crossref","first-page":"171\u2013","DOI":"10.1159\/000279334","article-title":"The incidence of myasthenia gravis: a systematic literature review.","volume":"34","author":"McGrogan","year":"2010;","journal-title":"Neuroepidemiology"},{"key":"key20250605073415_B2","doi-asserted-by":"crossref","first-page":"596981.","DOI":"10.3389\/fneur.2020.596981","article-title":"Myasthenia gravis: autoantibody specificities and their role in MG management.","volume":"11:","author":"Lazaridis","year":"2020;","journal-title":"Front Neurol"},{"issue":"(6):","key":"key20250605073415_B3","doi-asserted-by":"crossref","first-page":"1597.","DOI":"10.3390\/jcm11061597","article-title":"Current treatment of myasthenia gravis.","volume":"11","author":"Alhaidar","year":"2022;","journal-title":"J Clin Med"},{"issue":"(11):","key":"key20250605073415_B4","doi-asserted-by":"crossref","first-page":"2235.","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations.","volume":"10","author":"Dresser","year":"2021;","journal-title":"J Clin Med"},{"issue":"(1):","key":"key20250605073415_B5","doi-asserted-by":"crossref","first-page":"413\u2013","DOI":"10.1196\/annals.1254.054","article-title":"Myasthenia gravis (MG): epidemiological data and prognostic factors.","volume":"998","author":"Mantegazza","year":"2003;","journal-title":"Ann N Y Acad Sci"},{"issue":"(3):","key":"key20250605073415_B6","doi-asserted-by":"crossref","first-page":"352.","DOI":"10.4103\/0028-3886.43455","article-title":"Myasthenia gravis: a study from India.","volume":"56","author":"Singhal","year":"2008;","journal-title":"Neurol India"},{"key":"key20250605073415_B7","doi-asserted-by":"crossref","DOI":"10.4103\/aian.aian_945_22","article-title":"Clinical profile and quality of life in myasthenia gravis using MGQOL15 R (Hindi): an Indian perspective.","author":"Majigoudra","year":"2023.","journal-title":"Ann Indian Acad Neurol"},{"key":"key20250605073415_B8","first-page":"Doc12.","article-title":"Refractory myasthenia gravis \u2013 clinical profile, comorbidities and response to rituximab.","volume":"14:","author":"Sudulagunta","year":"2016;","journal-title":"GMS Ger Med Sci"},{"key":"key20250605073415_B9","doi-asserted-by":"crossref","first-page":"776.","DOI":"10.3389\/fimmu.2020.00776","article-title":"Autoimmune pathology in myasthenia gravis disease subtypes is governed by divergent mechanisms of immunopathology.","volume":"11:","author":"Fichtner","year":"2020;","journal-title":"Front Immunol"},{"key":"key20250605073415_B10","doi-asserted-by":"crossref","first-page":"46.","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in myasthenia gravis.","volume":"10:","author":"Carr","year":"2010;","journal-title":"BMC Neurol"},{"issue":"(2):","key":"key20250605073415_B11","doi-asserted-by":"crossref","first-page":"253\u2013","DOI":"10.1016\/j.ncl.2018.01.002","article-title":"Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology.","volume":"36","author":"Hehir","year":"2018;","journal-title":"Neurol Clin"},{"issue":"(10):","key":"key20250605073415_B12","first-page":"985\u2013","article-title":"Ocular myasthenia gravis: a review.","volume":"62","author":"Nair","year":"2014;","journal-title":"Indian J Ophthalmol"},{"key":"key20250605073415_B13","first-page":"14.","article-title":"Type 2 diabetes mellitus as a possible risk factor for myasthenia gravis: a case\u2013control study.","author":"Liu","year":"2023;","journal-title":"Front Neurol"},{"issue":"(3):","key":"key20250605073415_B14","doi-asserted-by":"crossref","first-page":"114\u2013","DOI":"10.1212\/WNL.0000000000011124","article-title":"International Consensus Guidance for Management of Myasthenia Gravis: 2020 update.","volume":"96","author":"Narayanaswami","year":"2021;","journal-title":"Neurology"},{"key":"key20250605073415_B15","first-page":"12.","article-title":"Comorbid autoimmune diseases in patients with myasthenia gravis: a retrospective cross-sectional study of a Chinese cohort.","author":"Shi","year":"2021;","journal-title":"Front Neurol"},{"issue":"(1):","key":"key20250605073415_B16","doi-asserted-by":"crossref","first-page":"6\u2013","DOI":"10.1002\/pnp.315","article-title":"Diagnosis and management of myasthenia gravis.","volume":"18","author":"Sathasivam","year":"2014;","journal-title":"Prog Neurol Psychiatr"},{"issue":"(1):","key":"key20250605073415_B17","doi-asserted-by":"crossref","first-page":"89.","DOI":"10.1186\/s12974-022-02448-4","article-title":"Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients.","volume":"19","author":"Nelke","year":"2022;","journal-title":"J Neuroinflammation"},{"key":"key20250605073415_B18","first-page":"12.","article-title":"Pneumonia in myasthenia gravis: microbial etiology and clinical management.","author":"Su","year":"2022;","journal-title":"Front Cell Infect Microbiol"},{"issue":"(2)","key":"key20250605073415_B19","article-title":"A late diagnosis of myasthenia gravis at the respiratory practice: back to basics.","volume":"18","author":"Santy","year":"2022;","journal-title":"Breathe"},{"issue":"(12):","key":"key20250605073415_B20","doi-asserted-by":"crossref","first-page":"2530\u2013","DOI":"10.1016\/j.clinph.2011.05.019","article-title":"Decremental responses to repetitive nerve stimulation (RNS) in motor neuron disease.","volume":"122","author":"Iwanami","year":"2011;","journal-title":"Clin Neurophysiol"},{"issue":"(1):","key":"key20250605073415_B21","first-page":"14.","article-title":"The use of the ice pack test in myasthenia gravis.","volume":"1","author":"Kearsey","year":"2010;","journal-title":"JRSM Short Rep"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T07:34:24Z","timestamp":1749108864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.japi.org\/article\/japi-73-3-40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.59556\/japi.73.0843"],"URL":"https:\/\/doi.org\/10.59556\/japi.73.0843","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}